Cambridge [England], April 30 (ANI): Researchers from the Wellcome Sanger Institute found that a specific genetic mutation, which is linked with poor prognosis in blood cancer, is involved in the development of the disease when combined with other mutations in mice and human cell lines.
Nagoya (Japan), April 22 (ANI): Researchers have uncovered a molecular pathway that enhances chemotherapy resistance in some pancreatic cancer patients. Targeting an RNA to interrupt its activity could improve patient response to therapy and increase their overall survival.
Washington D.C. [USA], Dec. 4 (ANI): US researchers have found that patients who can potentially benefit most from participation in clinical trials due to poor prognosis often are not included in eligibility criteria of existing medical illnesses.